Intelligence Β· Clinical Pipeline

Takeda Pipeline

All ClinicalTrials.gov programs at Takeda β€” phase, modality, and trial IDs.

Programs
154

Quick answer

Takeda has 154 clinical development programs indexed from ClinicalTrials.gov, including phase, modality, indication text, and linked NCT identifiers.

  1. pioglitazone

    Takeda

    Type 2 Diabetes

    approved small molecule completed

    1 trial
  2. pioglitazone

    Takeda

    Type 2 Diabetes Mellitus

    approved small molecule completed

    4 trials
  3. placebo

    Takeda

    Constipation

    approved small molecule completed

    1 trial
  4. prucalopride

    Takeda

    Chronic Constipation

    approved small molecule completed

    1 trial
  5. ramelteon

    Takeda

    Migraine Headache

    approved small molecule terminated

    1 trial
  6. rhPTH (1-84)

    Takeda

    Hypoparathyroidism

    approved mab completed

    3 trials
  7. rhPTH(1-84)

    Takeda

    Chronic Hypoparathyroidism

    approved small molecule terminated

    2 trials
  8. rt-PA

    Takeda

    Lacunar Stroke

    approved small molecule active

    1 trial
  9. theophylline

    Takeda

    Healthy

    approved small molecule completed

    1 trial
  10. vortioxetine

    Takeda

    Depression

    approved small molecule completed

    1 trial

Frequently asked questions

How many pipeline programs does Takeda have?

154 published programs are linked to this sponsor in our ClinicalTrials.gov index.

Is this the complete company pipeline?

This hub lists all published programs for the sponsor in our database. Partnered or out-licensed assets may appear under multiple companies.

Data attribution: Data sources Β· All pipeline programs